EW:NYSE
Edwards Lifesciences Corp
106,40 US$
arrow_upward
+0,56%(+0,59) 1D
12 ნოე, 12:58:07 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
106,07 US$
High
106,80 US$
Low
104,93 US$
Mkt. cap
61,18 მლრდ.
Avg. vol.
4,48 მლნ.
Volume
1,03 მლნ.
P/E ratio
60,32
52-wk high
106,80 US$
52-wk low
74,66 US$
EPS
1,76 US$
Beta
0,85
Shares outstanding
575,00 მლნ.
No. of employees
16 ათ.
Open
106,07 US$
High
106,80 US$
Low
104,93 US$
Mkt. cap
61,18 მლრდ.
Avg. vol.
4,48 მლნ.
Volume
1,03 მლნ.
P/E ratio
60,32
52-wk high
106,80 US$
52-wk low
74,66 US$
EPS
1,76 US$
Beta
0,85
Shares outstanding
575,00 მლნ.
No. of employees
16 ათ.
News stories
From web sources and news partners
News Corp
·
20 საათის წინ
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Investing.com
·
22 საათის წინ
Edwards Lifesciences stock hits 52-week high at 105.39 USD
Investing.com
·
3 დღის წინ
Edwards Lifesciences stock rating maintained at Buy by TD Cowen
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 ათ.
Founded1958
Headquartersირვაინი, კალიფორნია, ამერიკის შეერთებული შტატები
SectorHealth Care
IndustryMedical device
Websiteedwards.com